The value of serum levels of IL-6, TNF-alpha, and erythropoietin in metastatic malignant melanoma: serum IL-6 level is a valuable prognostic factor at least as serum LDH in advanced melanoma (Q81085136)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 January 2005

Language	Label	Description	Also known as
English	The value of serum levels of IL-6, TNF-alpha, and erythropoietin in metastatic malignant melanoma: serum IL-6 level is a valuable prognostic factor at least as serum LDH in advanced melanoma	scientific article published on 01 January 2005

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16110135%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

The value of serum levels of IL-6, TNF-alpha, and erythropoietin in metastatic malignant melanoma: serum IL-6 level is a valuable prognostic factor at least as serum LDH in advanced melanoma (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16110135%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

Faruk Tas

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16110135%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Hilal Oguz

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16110135%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Andaç Argon

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16110135%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Derya Duranyildiz

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16110135%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Hakan Camlica

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16110135%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Vildan Yasasever

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16110135%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Erkan Topuz

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16110135%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

publication date

1 January 2005

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16110135%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Medical Oncology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16110135%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

22

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16110135%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16110135%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

241-246

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16110135%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

https://scigraph.springernature.com/pub.10.1385/mo:22:3:241

0 references

Prognostic factors in metastatic melanoma: a pooled analysis of Eastern Cooperative Oncology Group trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/16110135

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endogenous interleukin 6 levels in patients with metastatic malignant melanoma: correlation with tumor burden

1 reference

https://pubmed.ncbi.nlm.nih.gov/16110135

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor necrosis factor-alpha augmented tumor response in B16BL6 melanoma-bearing mice treated with stealth liposomal doxorubicin (Doxil) correlates with altered Doxil pharmacokinetics

1 reference

https://pubmed.ncbi.nlm.nih.gov/16110135

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is there any relationship between interleukin-6/interleukin-6 receptor modulation and endogenous interleukin-6 release in metastatic malignant melanoma patients treated by biochemotherapy?

1 reference

https://pubmed.ncbi.nlm.nih.gov/16110135

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum interleukin-6 concentrations as predictive factor of time to progression in metastatic malignant melanoma patients treated by biochemotherapy: a retrospective study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16110135

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum values of tumour necrosis factor-alpha and of soluble tumour necrosis factor-R55 in melanoma patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/16110135

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The value of serum S-100beta and interleukins as tumour markers in advanced melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/16110135

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic factors in metastatic malignant melanoma. The southeastern cancer study group experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/16110135

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of blocking TNF on IL-6 levels and metastasis in a B16-BL6 melanoma/mouse model

1 reference

https://pubmed.ncbi.nlm.nih.gov/16110135

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Erythropoietin receptor expression in human melanoma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/16110135

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III)

1 reference

https://pubmed.ncbi.nlm.nih.gov/16110135

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic factors in metastatic malignant melanoma. An analysis of 236 patients treated on clinical research studies at the Department of Medical Oncology, University of Pretoria, South Africa from 1972-1992

1 reference

https://pubmed.ncbi.nlm.nih.gov/16110135

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Erythropoietin regulates tumour growth of human malignancies.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16110135

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic factors for survival and factors associated with long-term remission in patients with advanced melanoma receiving cytokine-based treatments: second analysis of a randomised EORTC Melanoma Group trial comparing interferon-alpha2a (IFNalpha

1 reference

https://pubmed.ncbi.nlm.nih.gov/16110135

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum imbalance of cytokines in melanoma patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/16110135

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-6 and its surrogate C-reactive protein are useful serum markers for monitoring metastasized malignant melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/16110135

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic factors in 1,521 melanoma patients with distant metastases.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16110135

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic factors for survival of patients treated systemically for disseminated melanoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16110135

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumour necrosis factor alpha: a potential target for the therapy of solid tumours.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16110135

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of endogenous interleukin-6 on Fas (APO-1/CD95) receptor expression in advanced melanoma patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/16110135

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic factors in metastatic melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/16110135

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prolonged survival of 2 years or longer for patients with disseminated melanoma. An analysis of related prognostic factors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16110135

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum erythropoietin levels in patients with solid tumours

1 reference

https://pubmed.ncbi.nlm.nih.gov/16110135

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic factors in patients with metastatic malignant melanoma. A multivariate analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16110135

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q81085136&oldid=1759538686"